Maintain a balanced diet to complement supplementation
At SynergenX, PT-141 is offered as part of a personalized, provider-guided treatment plan for women experiencing low libido, reduced arousal, or changes in sexual health
35 KDIGO: According to the KDIGO 2022 DM and CKD guidelines and the 2024 CKD guidelines, long-acting GLP-1 receptor agonists are recommended for treating type 2 diabetes patients with CKD
PlexusDx removes barriers to access by partnering with licensed prescribers nationwide and offering compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, making personalized weight loss therapy available to all 50 states without membership fees or prior authorization delays
It is important to consult a healthcare provider before use in these cases.
All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis